The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs
The New York Times - 10 Jul 2025 23:42
The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.
Share this Article
Recommended